相关实验视频
Updated: Jan 8, 2026

10:49
Measuring RAN Peptide Toxicity in C. elegans
Published on: April 30, 2020
7.0K
在鼻癌中,A11通过降解EphA2来增强辐射敏感性
Ming Zhang1,2, Zhi-Qiang Xiao1,2, Wei Huang1,2
1Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital, Central South University, Changsha, China.
Cancer science
|December 12, 2025
概括
高水平的EphA2蛋白表达驱动了鼻癌 (NPC) 中的放射电阻. 沉默EphA2或使用A11增强了放射敏感性,为NPC患者提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 放射治疗研究 放射治疗研究
背景情况:
- 鼻癌 (NPC) 呈现出显著的放射电阻,导致临床结果不佳.
- 过度表达EphA2蛋白与各种癌症的瘤进展和转移有关.
研究的目的:
- 研究EphA2在NPC电阻中的作用和机制.
- 评估A11在克服NPC电阻方面的治疗潜力.
主要方法:
- 对104个NPC组织进行临床分析,将EphA2表达与放射电阻相关联.
- 使用EphA2-敲除NPC细胞系 (体外和体内模型) 的功能研究.
- 研究EphA2介导的信号级联 (RSK-EphA2-AKT) 和A11的影响.
主要成果:
- 在NPC组织中的高EphA2表达与放射电阻和降低整体存活率有显著的相关性.
- 在实验室和体内,EphA2敲击增强了NPC细胞的辐射敏感性.
- 通过在Ser897的辐射诱导RSK介导酸化,EphA2驱动放射电阻,激活AKT通路.
- A11降解了EphA2并阻断了其S897酸化,显著改善了辐射敏感性.
结论:
- 过度表达EphA2及其S897酸化是NPC中放射电阻的关键驱动因素.
- A11通过向EphA2来证明治疗潜力,提供了一种提高NPC放射治疗疗效的策略.
相关概念视频
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.6K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K

